Robyn Karnauskas

Stock Analyst at Truist Securities

(2.35)
# 2,493
Out of 4,711 analysts
179
Total ratings
40%
Success rate
-0.15%
Average return

Stocks Rated by Robyn Karnauskas

Merck & Co.
Nov 7, 2024
Maintains: Buy
Price Target: $132$130
Current: $98.05
Upside: +32.59%
Amgen
Oct 14, 2024
Downgrades: Hold
Price Target: $320$333
Current: $263.38
Upside: +26.43%
Gilead Sciences
Aug 15, 2024
Maintains: Hold
Price Target: $82$83
Current: $92.57
Upside: -10.34%
AbbVie
Jul 26, 2024
Reiterates: Buy
Price Target: $195$210
Current: $175.58
Upside: +19.60%
Biomea Fusion
Jun 11, 2024
Downgrades: Hold
Price Target: n/a
Current: $4.23
Upside: -
Biogen
May 16, 2024
Maintains: Buy
Price Target: $340
Current: $146.47
Upside: +132.13%
Curis
May 15, 2024
Maintains: Buy
Price Target: $26
Current: $3.08
Upside: +744.16%
Coherus BioSciences
May 13, 2024
Maintains: Buy
Price Target: $8$7
Current: $1.52
Upside: +360.53%
Regeneron Pharmaceuticals
Apr 3, 2024
Maintains: Buy
Price Target: $1,135
Current: $701.85
Upside: +61.72%
OmniAb
Mar 26, 2024
Maintains: Buy
Price Target: $10
Current: $3.50
Upside: +185.71%
Maintains: Buy
Price Target: $9
Current: $2.99
Upside: +201.00%
Reiterates: Buy
Price Target: $74
Current: $20.65
Upside: +258.35%
Reiterates: Buy
Price Target: $23
Current: $11.57
Upside: +98.79%
Reiterates: Buy
Price Target: $48
Current: $25.86
Upside: +85.61%
Reiterates: Buy
Price Target: $50
Current: $15.50
Upside: +222.58%
Reiterates: Buy
Price Target: $850
Current: $767.76
Upside: +10.71%
Maintains: Buy
Price Target: $456$508
Current: $397.27
Upside: +27.87%
Maintains: Buy
Price Target: $42$36
Current: $26.36
Upside: +36.57%
Reiterates: Buy
Price Target: $84
Current: $57.33
Upside: +46.52%
Downgrades: Hold
Price Target: $25
Current: $46.24
Upside: -45.93%
Downgrades: Hold
Price Target: n/a
Current: $0.34
Upside: -
Reiterates: Buy
Price Target: $140
Current: $65.66
Upside: +113.22%
Reiterates: Buy
Price Target: $150
Current: $1.21
Upside: +12,296.69%
Reiterates: Hold
Price Target: $7
Current: $1.68
Upside: +316.67%
Maintains: Buy
Price Target: $65$55
Current: $16.98
Upside: +223.91%
Downgrades: Hold
Price Target: n/a
Current: $2.50
Upside: -
Initiates: Buy
Price Target: $29
Current: $2.85
Upside: +917.54%
Maintains: Buy
Price Target: $500$320
Current: $20.61
Upside: +1,452.64%
Maintains: Buy
Price Target: $10$15
Current: $8.65
Upside: +73.41%
Initiates: Buy
Price Target: $25
Current: $3.34
Upside: +648.48%
Initiates: Buy
Price Target: $85
Current: $0.88
Upside: +9,557.99%